Suppr超能文献

[用于乳房内给药的含利福霉素SV剂型的临床前研究]

[Preclinical research on drug forms containing rifamycin SV intended for intramammary use].

作者信息

Pashov D, Drumev D, Marinkov T

出版信息

Vet Med Nauki. 1987;24(10):21-7.

PMID:3450076
Abstract

It was established, that LD50 of rifamycin SV--sodium salt, produced by the Research Institute on Microbiological Industry--Razgrad (People's Republic of Bulgaria)--RM, at p.o. applying on albino mice, albino rats and broilers is correspondingly greater than 4100.0 mg/kg m., greater than 5740.0 mg/kg m. and 1951.6 (1355.5 divided by 2810.1) mg/kg m. and at s. c. introducing into albino mice--815.9 (756.9 divided by 879.9) mg/kg m. From the prepared on the basis of RM-4 intramammary medicaments--RM-1, RM-2 and RM-3 for lactating cows and RM-4 for cows in the dry period, a good bearing have RM-1, RM-3 and RM-4. RM-1, RM-2 and RM-3, applied intracisternally a single time on lactating cows, and RM-4 on cows in the dry period, create antimicrobial levels with duration correspondingly 168, 72 and 48 h, and 35 days. RM almost does not penetrate in the neighbouring not treated quarters. Appropriate medicament for the lactating cows with average duration of emission is RM-3 (term of action 96 h) and for cows in the dry period RM-4 when applied 35 days before the calving.

摘要

已确定,保加利亚人民共和国拉兹格勒微生物工业研究所生产的利福霉素SV钠盐,经口给白化小鼠、白化大鼠和肉鸡使用时,其半数致死量(LD50)分别大于4100.0毫克/千克体重、大于5740.0毫克/千克体重和1951.6(1355.5除以2810.1)毫克/千克体重;经皮下给白化小鼠使用时,其半数致死量为815.9(756.9除以879.9)毫克/千克体重。在基于RM - 4制备的用于泌乳奶牛的乳房内用药RM - 1、RM - 2和RM - 3以及用于干奶期奶牛的RM - 4中,RM - 1、RM - 3和RM - 4耐受性良好。RM - 1、RM - 2和RM - 3单次经脑池内给泌乳奶牛使用,RM - 4给干奶期奶牛使用,可分别产生持续168小时、72小时和48小时以及35天的抗菌水平。RM几乎不会渗透到未处理的相邻乳腺。对于平均排乳期的泌乳奶牛,合适的药物是RM - 3(作用期96小时);对于干奶期奶牛,在产犊前35天使用RM - 4。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验